Managing tardive dyskinesia.
Tardive dyskinesia, a delayed side effect of neuroleptic drugs, requires early recognition and a systematic treatment plan. An outline is presented which offers guidelines for management strategies and drug treatments, along with a summary of recent developments.
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002794:Choline / Q000627:therapeutic use; D003642:Deanol / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000187:drug effects*; D012110:Reserpine / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D003642:Deanol; D012110:Reserpine; D008094:Lithium; D002794:Choline